News and Announcements
TreeCoin’s Global Expansion: Innovating Carbon Markets with Blockchain Technology
- Published October 15, 2024 7:40AM UTC
- Publisher Maan Perez
- Categories Executive Interviews
Join us for an Executive Interview with TreeCoin’s CEO Demian Natakhan and Product Manager Luke Bonnici as they discuss the company’s ambitious plans to transform the carbon market. Learn how TreeCoin aims to achieve a $300 million valuation by leveraging blockchain technology for carbon tokenisation and reforestation projects worldwide. This video provides a comprehensive look at TreeCoin’s innovative strategies and key partnerships driving their success.
Executive Interviews
Jamie Dimon: Navigating a World of Uncertainty – From Recession Risks to Geopolitical Tensions
In a candid interview with Bloomberg, JPMorgan Chase CEO Jamie Dimon offered a nuanced perspective on the current global economic landscape, a panorama he describes as rife with “a lot of uncertainty.” From lingering recession fears in the US to the complex interplay of trade wars and geopolitical tensions, Dimon, ever the realist, painted a […]
Wholesale Investor and CapitalHQ Sign Exclusive Master Licence with inQ Innovation Global to Provide Access to India’s High-Growth Startup Market
Wholesale Investor and inQ Innovation have forged a strategic partnership, granting global investors direct access to India’s rapidly expanding innovation ecosystem. This exclusive three-year agreement leverages CapitalHQ’s technology to streamline fundraising for Indian startups and expand deal flow for WI’s 45,000-strong investor network, aligning with India’s 2030 Vision for economic growth and innovation.
EBR Systems: Aussie Medtech Ready to Disrupt $3.6B Heart Failure Market with Leadless Pacemaker
Andrew Shute, Senior Vice President of Business Development at EBR Systems, is confident that his Australian medical device company is poised to make a significant impact on the global cardiac rhythm management market. The focus? A novel leadless pacemaker designed to revolutionise treatment for heart failure patients. After years of development and rigorous clinical trials, […]
Backed By Leading Investment Groups and Family Offices
